Business

  • From awareness to adoption: Why strategic PR is a growth engine for health tech

    By EatMoreFruit Communications Many health tech and medical device firms spend years refining technology, securing CE marks and FDA approvals, only to stumble at market launch. The missing link? Strategic PR that drives stakeholders from passive awareness to active adoption. The Adoption Funnel in Numbers According to Deloitte’s 2025 Global MedTech Survey, 61 per cent [...]

  • FINN Partners appoints Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead

    Global integrated marketing and communications agency FINN Partners has appointed Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead. Taylor-Roberts will lead the FINN UK Health Group in strengthening its reputation as a leading communications partner for the biopharma, medical device and health system sectors. She succeeds Julie Adrian, who returned to her role [...]

  • System C acquires MYP Technologies to drive international growth

    System C today announced the acquisition of Australian health and care management tech provider MYP Technologies. This strategic move deepens System C’s presence in the region and supports ambitious plans to expand its social care and maternity product offerings across Australia and New Zealand. The acquisition marks a significant step in System C’s international growth [...]

  • How the UK can reclaim its leadership in pharmaceutical R&D

    By Younes Fegheh-Hassanpour PhD., R&D Manager at RCK Partners The UK’s pharmaceutical industry is at a critical juncture. A post-pandemic rebound has seen export values climb back to £26.1 billion in 2023, but beneath this promising headline, challenges persist. Once a global leader, the UK now trails in tenth place for pharmaceutical exports as challenges [...]

  • Numan raises US$60m to expand digital health services

    UK digital health company Numan has raised US$60m to expand its platform, focusing on preventive care, enhanced screening and women’s health. The funding extends Numan’s Series B round and comes after a year in which its revenue more than doubled to US$90m. The platform has now treated over 650,000 patients across obesity care, men’s health [...]

  • UK launches £2bn life sciences strategy

    The UK government has launched a £2bn life sciences strategy aimed at driving growth, speeding up innovation, and transforming NHS healthcare. Life sciences is one of eight priority sectors in the UK’s Industrial Strategy. The ten-year plan aims to boost an industry worth around £100bn and employing around 300,000 people. The strategy focuses on three [...]

  • UK companies invited to join ABHI UK Pavilion at WHX Cape Town 2025

    The Association of British HealthTech Industries (ABHI) is inviting UK HealthTech companies to join the ABHI UK Pavilion at WHX Cape Town 2025, taking place from 2 - 4 September 2025 at the Cape Town International Convention Centre. The event offers a unique platform for UK innovators to partner with African healthcare providers, distributors, and [...]

  • McDermott advises Great Point Partners on financing of MLM‘s acquisition of Cytespace Africa Laboratories

    McDermott Will & Emery has advised Great Point Partners (GPP) on the financing of the acquisition of Cytespace Africa Laboratories by MLM Medical Labs (MLM), a portfolio company of GPP. With this strategic acquisition MLM expands their global footprint into South Africa. MLM Medical Labs headquartered in Mönchengladbach, Germany, with additional laboratories in Memphis, Tennessee, [...]

  • SuperDial raises $15M to automate healthcare’s endless admin phone calls

    SuperDial has announced $15 million in new funding to scale its voice AI platform, which automates high-friction insurance calls that cost provider organisations and billing companies billions of dollars every year. The debt and equity series A round was led by SignalFire, with participation from Slow Ventures, Box Group, and Scrub Capital. It includes $3 [...]

  • McDermott advises GPP on acquiring a majority stake in Eutecma

    McDermott Will & Emery advised Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the healthcare industry, on the acquisition of a majority stake in Eutecma, a German-based developer of packaging solutions for pharmaceutical cold chain shipments. With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its [...]